MYOM2 and plasma cell myeloma: With routine SPEP screening, we had the unique opportunities to observe the prevalence of monoclonal gammopathy in a large-scale hospital population and to identify patients with early-stage myeloma via the M-protein screening-driven diagnostic approach.